Skip to main content
Erschienen in: Digestive Diseases and Sciences 1/2012

01.01.2012 | Original Article

Accuracy of Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreas Divisum

verfasst von: Patrick Mosler, F. Akisik, K. Sandrasegaran, E. Fogel, J. Watkins, W. Alazmi, S. Sherman, G. Lehman, T. Imperiale, L. McHenry

Erschienen in: Digestive Diseases and Sciences | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with pancreas divisum may develop pancreatitis. Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard for diagnosing pancreas divisum. Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive test reported to be highly accurate in diagnosing pancreas divisum.

Aim

To evaluate the diagnostic accuracy of MRCP in detecting pancreas divisum at our institution.

Methods

We reviewed patients who underwent both ERCP and MRCP. Patients who had diagnostic endoscopic pancreatograms (ERP) after MRCP comprise the study population. Secretin was given in 113/146 patients (S-MRCP). The remaining 33/146 patients had MRCP without secretin. In 7/33 patients who underwent MRCP without secretin (21.2%), the studies were non-diagnostic and, therefore, this group was not further analyzed and the study focused on the S-MRCP group only.

Results

ERP identified pancreas divisum in 19/113 (16.8%) patients. S-MRCP identified 14/19 pancreas divisum and was false-positive in three cases (sensitivity 73.3%, specificity 96.8%, positive predictive value 82.4%, negative predictive value 94.8%). Of the eight patients with inaccurate S-MRCP, 5 (63%) had changes of chronic pancreatitis by ERP. This differs from the frequency of chronic pancreatitis by ERP in 24/105 (23%) patients with accurate MRCP findings. The ERCP findings of chronic pancreatitis were more frequent among incorrect S-MRCP interpretations than among correct interpretations (odds ratio [OR] 5.5 [95% confidence interval (CI) 1.3–25.3]).

Summary

MRCP without secretin is non-diagnostic for pancreas divisum in a significant proportion of patients. S-MRCP had a satisfactory specificity for detecting pancreas divisum. However, the sensitivity of S-MRCP for the diagnosis of pancreas divisum was modest at 73.3%. This is low compared to previous smaller studies, which reported a sensitivity of MRCP of up to 100%.
Literatur
1.
Zurück zum Zitat Suga T, Nagakawa T, Miyakawa H, et al. Clinical features of patients with pancreas divisum. Dig Endosc. 1994;6:80–86.CrossRef Suga T, Nagakawa T, Miyakawa H, et al. Clinical features of patients with pancreas divisum. Dig Endosc. 1994;6:80–86.CrossRef
3.
Zurück zum Zitat Park DH, Kim MH, Lee SS, et al. Accuracy of magnetic resonance cholangiopancreatography for locating hepatolithiasis and detecting accompanying biliary strictures. Endoscopy. 2004;36:987–992.PubMedCrossRef Park DH, Kim MH, Lee SS, et al. Accuracy of magnetic resonance cholangiopancreatography for locating hepatolithiasis and detecting accompanying biliary strictures. Endoscopy. 2004;36:987–992.PubMedCrossRef
4.
Zurück zum Zitat Farrell RJ, Noonan N, Mahmud N, et al. Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain. Endoscopy. 2001;33:668–675.PubMedCrossRef Farrell RJ, Noonan N, Mahmud N, et al. Potential impact of magnetic resonance cholangiopancreatography on endoscopic retrograde cholangiopancreatography workload and complication rate in patients referred because of abdominal pain. Endoscopy. 2001;33:668–675.PubMedCrossRef
5.
Zurück zum Zitat Taylor AC, Little AF, Hennessy OF, et al. Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc. 2002;55:17–22.PubMedCrossRef Taylor AC, Little AF, Hennessy OF, et al. Prospective assessment of magnetic resonance cholangiopancreatography for noninvasive imaging of the biliary tree. Gastrointest Endosc. 2002;55:17–22.PubMedCrossRef
6.
Zurück zum Zitat Scheiman JM, Carlos RC, Barnett JL, et al. Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis. Am J Gastroenterol. 2001;96:2900–2904.PubMedCrossRef Scheiman JM, Carlos RC, Barnett JL, et al. Can endoscopic ultrasound or magnetic resonance cholangiopancreatography replace ERCP in patients with suspected biliary disease? A prospective trial and cost analysis. Am J Gastroenterol. 2001;96:2900–2904.PubMedCrossRef
7.
Zurück zum Zitat Soto JA, Barish MA, Yucel EK, et al. Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology. 1996;110:589–597.PubMedCrossRef Soto JA, Barish MA, Yucel EK, et al. Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography. Gastroenterology. 1996;110:589–597.PubMedCrossRef
8.
Zurück zum Zitat Sugiyama M, Atomi Y, Hachiya J. Magnetic resonance cholangiography using half-Fourier acquisition for diagnosing choledocholithiasis. Am J Gastroenterol. 1998;93:1886–1890.PubMedCrossRef Sugiyama M, Atomi Y, Hachiya J. Magnetic resonance cholangiography using half-Fourier acquisition for diagnosing choledocholithiasis. Am J Gastroenterol. 1998;93:1886–1890.PubMedCrossRef
9.
Zurück zum Zitat Bret PM, Reinhold C, Taourel P, et al. Pancreas divisum: evaluation with MR cholangiopancreatography. Radiology. 1996;199:99–103.PubMed Bret PM, Reinhold C, Taourel P, et al. Pancreas divisum: evaluation with MR cholangiopancreatography. Radiology. 1996;199:99–103.PubMed
10.
Zurück zum Zitat Matos C, Metens T, Devière J, et al. Pancreas divisum: evaluation with secretin-enhanced magnetic resonance cholangiopancreatography. Gastrointest Endosc. 2001;53:728–733.PubMedCrossRef Matos C, Metens T, Devière J, et al. Pancreas divisum: evaluation with secretin-enhanced magnetic resonance cholangiopancreatography. Gastrointest Endosc. 2001;53:728–733.PubMedCrossRef
11.
Zurück zum Zitat Kim S, Kim M, Park D, et al. Secretin-enhanced magnetic resonance cholangio-pancreatography (S-MRCP) in pancreatic diseases. Gastrointest Endosc. 2003;57AB:T1573. Kim S, Kim M, Park D, et al. Secretin-enhanced magnetic resonance cholangio-pancreatography (S-MRCP) in pancreatic diseases. Gastrointest Endosc. 2003;57AB:T1573.
12.
Zurück zum Zitat Ueno E, Takada Y, Yoshida I, et al. Pancreatic diseases: evaluation with MR cholangiopancreatography. Pancreas. 1998;16:418–426.PubMedCrossRef Ueno E, Takada Y, Yoshida I, et al. Pancreatic diseases: evaluation with MR cholangiopancreatography. Pancreas. 1998;16:418–426.PubMedCrossRef
13.
Zurück zum Zitat Manfredi R, Costamagna G, Brizi MG, et al. Pancreas divisum and “santorinicele”: diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Radiology. 2000;217:403–408.PubMed Manfredi R, Costamagna G, Brizi MG, et al. Pancreas divisum and “santorinicele”: diagnosis with dynamic MR cholangiopancreatography with secretin stimulation. Radiology. 2000;217:403–408.PubMed
14.
Zurück zum Zitat Carnes ML, Romagnuolo J, Cotton PB. Miss rate of pancreas divisum by magnetic resonance cholangiopancreatography in clinical practice. Pancreas. 2008;37:151–153.PubMedCrossRef Carnes ML, Romagnuolo J, Cotton PB. Miss rate of pancreas divisum by magnetic resonance cholangiopancreatography in clinical practice. Pancreas. 2008;37:151–153.PubMedCrossRef
15.
Zurück zum Zitat Soto JA, Lucey BC, Stuhlfaut JW. Pancreas divisum: depiction with multi-detector row CT. Radiology. 2005;235:503–508.PubMedCrossRef Soto JA, Lucey BC, Stuhlfaut JW. Pancreas divisum: depiction with multi-detector row CT. Radiology. 2005;235:503–508.PubMedCrossRef
16.
Zurück zum Zitat Lai R, Freeman ML, Cass OW, et al. Accurate diagnosis of pancreas divisum by linear-array endoscopic ultrasonography. Endoscopy. 2004;36:705–709.PubMedCrossRef Lai R, Freeman ML, Cass OW, et al. Accurate diagnosis of pancreas divisum by linear-array endoscopic ultrasonography. Endoscopy. 2004;36:705–709.PubMedCrossRef
17.
Zurück zum Zitat Vaughan RB, Mainie I, Hoffman B, et al. Accuracy of endoscopic ultrasound in the diagnosis of pancreas divisum in a busy clinical setting. Gastrointest Endosc. 2006;63:AB263.CrossRef Vaughan RB, Mainie I, Hoffman B, et al. Accuracy of endoscopic ultrasound in the diagnosis of pancreas divisum in a busy clinical setting. Gastrointest Endosc. 2006;63:AB263.CrossRef
Metadaten
Titel
Accuracy of Magnetic Resonance Cholangiopancreatography in the Diagnosis of Pancreas Divisum
verfasst von
Patrick Mosler
F. Akisik
K. Sandrasegaran
E. Fogel
J. Watkins
W. Alazmi
S. Sherman
G. Lehman
T. Imperiale
L. McHenry
Publikationsdatum
01.01.2012
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 1/2012
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-011-1823-7

Weitere Artikel der Ausgabe 1/2012

Digestive Diseases and Sciences 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.